Literature DB >> 7943574

Contrasting roles of rivers and wells as sources of drinking water on attack and fatality rates in a hepatitis E epidemic in Somalia.

K Bile1, A Isse, O Mohamud, P Allebeck, L Nilsson, H Norder, I K Mushahwar, L O Magnius.   

Abstract

In early 1988, an increased incidence of acute hepatitis was observed in villages along the Shebeli River in the Lower Shebeli region of Somalia. This was followed by a large epidemic that lasted until late 1989. In a survey of 142 villages with a population of 245,312 individuals, 11,413 icteric cases were recorded, of which 346 died, corresponding to an attack rate and a case fatality rate of 4.6% and 3.0%, respectively. The etiologic role of hepatitis E virus (HEV) in this epidemic was proven by demonstrating anti-HEV in 128 of 145 sampled cases as a sign of recent infection with HEV. In three villages, where a special study protocol was implemented, the attack rate was found to increase significantly with age from 5% in the group 1-4 years of age to 13% in the group 5-15 years of age and to 20% for persons older than 15 years of age. Among cases 20-39 years of age, the female-to-male ratio was 1.5:1, which was a significant predominance of females. As in other hepatitis E outbreaks, there was a high fatality rate in pregnant females, estimated to be 13.8%. The epidemic peaked with the rise in the level of the river during rainfall, suggesting that the disease was waterborne. The attack rate was higher (6.0%) in villages supplied with river water, while fewer cases were recorded in those relying on wells or ponds for their water supply, 1.7% and 1.2%, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7943574

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  32 in total

1.  Novel risk factors associated with hepatitis E virus infection in a large outbreak in northern Uganda: results from a case-control study and environmental analysis.

Authors:  Christopher M Howard; Thomas Handzel; Vincent R Hill; Scott P Grytdal; Curtis Blanton; Saleem Kamili; Jan Drobeniuc; Dale Hu; Eyasu Teshale
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

2.  Clinical and epidemiological aspects of a hepatitis E outbreak in Bangui, Central African Republic.

Authors:  Alice I Goumba; Xavier Konamna; Narcisse P Komas
Journal:  BMC Infect Dis       Date:  2011-04-14       Impact factor: 3.090

Review 3.  Hepatitis e and acute liver failure in pregnancy.

Authors:  Subrat K Acharya
Journal:  J Clin Exp Hepatol       Date:  2013-09-05

4.  Risk factors and immune response to hepatitis E viral infection among acute hepatitis patients in Assiut, Egypt.

Authors:  Salwa S Seif Eldin; Ismail Seddik; Enas A Daef; M T Shata; Marwa Raafat; Laila Abdel Baky; M A Nafeh
Journal:  Egypt J Immunol       Date:  2010

5.  The Enigma of Hepatitis E Virus.

Authors:  Liza Bronner Murrison; Kenneth E Sherman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-08

6.  Epidemiological, Clinical and Entomological Characteristics of Yellow Fever Outbreak in Darfur 2012.

Authors:  Hamdi Abdulwahab Alhakimi; Omima Gadalla Mohamed; Hayat Salah Eldin Khogaly; Khalid Ahmad Omar Arafa; Waled Amen Ahmed
Journal:  AIMS Public Health       Date:  2015-03-25

7.  Estimating the burden of maternal and neonatal deaths associated with jaundice in Bangladesh: possible role of hepatitis E infection.

Authors:  Emily S Gurley; Amal K Halder; Peter K Streatfield; Hossain M S Sazzad; Tarique M Nurul Huda; M Jahangir Hossain; Stephen P Luby
Journal:  Am J Public Health       Date:  2012-10-18       Impact factor: 9.308

Review 8.  New perspectives on hepatitis E.

Authors:  Kenneth C Hyams
Journal:  Curr Gastroenterol Rep       Date:  2002-08

9.  Epidemiology, diagnosis, vaccines, and bibliometric analysis of the 100 top-cited studies on Hepatitis E virus.

Authors:  Tauseef Ahmad; Saima Nasir; Taha Hussein Musa; Saif Aldeen S AlRyalat; Muhammad Khan; Jin Hui
Journal:  Hum Vaccin Immunother       Date:  2020-08-05       Impact factor: 3.452

10.  Hepatitis E virus antibodies in patients with chronic liver disease.

Authors:  Muslim Atiq; Norah J Shire; Anna Barrett; Susan D Rouster; Kenneth E Sherman; Mohamed T Shata
Journal:  Emerg Infect Dis       Date:  2009-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.